Bliss GVS Pharma Limited — AGM Information 2025

Jul 31, 2025

==> picture [452 x 40] intentionally omitted <==

July 31, 2025

To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197

Dear Sir/Madam,

Subject: Disclosure of events or information – 40[th] Annual General Meeting held on Thursday, July 31, 2025

According to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the 40[th] Annual General Meeting held on Thursday, July 31, 2025, at 11:30 a.m. through Video Conferencing (“VC”)/Other Audio-Visual Means (“OAVM”).

Kindly take the above intimation in your record.

Thanking you.

Yours faithfully,

For Bliss GVS Pharma Limited

Digitally signed by ADITI ADITI HIMANSHU HIMANSHU BHATT BHATT Date: 2025.07.31 19:15:02 +05'30' Aditi Bhatt Company Secretary

Encl: As above

==> picture [452 x 65] intentionally omitted <==

==> picture [452 x 40] intentionally omitted <==

Proceedings of 40[th] Annual General Meeting of Bliss GVS Pharma Limited

The 40[th] Annual General Meeting (“ the Meeting or 40[th] AGM ”) of the Members of Bliss GVS Pharma Limited (“ the Company ”) was held on Thursday, July 31, 2025, through Video Conferencing (“VC”) /Other Audio-Visual Means (“OAVM”) pursuant General Circulars dated April 08, 2020, April 13, 2020, May 05, 2020, January 13, 2021, December 08, 2021, December 14, 2021, May 05, 2022, December 28, 2022, September 25, 2023 and September 19, 2024 issued by the Ministry of Corporate Affairs (“ MCA Circulars ”) along with the Circulars issued by Securities and Exchange Board of India dated May 12, 2020, January 15, 2021, May 13, 2022, January 05, 2023, October 07, 2023 and October 03, 2024 (“ SEBI Circulars ”) and in compliance with the provisions of the Companies Act, 2013 (“ Act ”) and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“ Listing Regulations ”). The meeting was scheduled and commenced at 11.30 a.m.

Mr. Nandkumar Chodankar, Chairman of the Board of Directors, chaired the proceedings of the 40[th] AGM of the Company.

Directors and KMPs in attendance:

Mr. Nandkumar Chodankar - Chairman & Independent Director, Chairman of the Stakeholder Relationship Committee & Corporate Social Responsibility Committee, Mr. Gagan Harsh Sharma - Managing Director, Mrs. Shruti Rao – Whole-Time Director, Dr. Vibha Sharma – Whole-Time Director, Mrs. Shilpa Bhatia, Independent Woman Director, Chairperson of Risk Management Committee, Mr. Deepak Sawant - Chief Financial Officer and Ms. Aditi Bhatt – Company Secretary had joined the meeting through VC from the Registered Office of the Company.

Mr. Santosh Parab, Independent Director & Chairman of the Audit Committee and Nomination and Remuneration Committee had joined the meeting through VC from his office in Mumbai.

Other Representatives:

Mr. Vijay Yadav, Partner of AVS & Associates, Practicing Company Secretaries, Secretarial Auditor of the Company & Scrutinizer of 40[th] AGM joined the meeting through VC from registered office of the Company.

Mr. Jamshed Udwadia, Partner of M/s. Kalyaniwalla & Mistry LLP, Statutory Auditor of the Company attended the meeting through VC from his respective location.

Mr. Hiren Upadhyay, Partner of BDO India LLP, Internal Auditor of the Company attended the meeting through VC from his respective location.

==> picture [452 x 65] intentionally omitted <==

==> picture [452 x 40] intentionally omitted <==

Members Present:

95 Members attended the meeting through VC, including those present in person from the Registered Office of the Company.

Proceedings in Brief:

Mr. Nandkumar Chodanakar – Chairman & Independent Director of the Company chaired the Meeting. He welcomed all the Directors and Shareholders of the Company to the 40[th] AGM. He then introduced the Directors on the Board and other representatives one by one. The requisite quorum being present, the Chairman called the Meeting to order.

Thereafter, the Chairman requested Ms. Aditi Bhatt, Company Secretary of the Company, to explain the procedural and technical aspects to the shareholders for attending the meeting. She informed the members that the company had made feasible efforts to enable members to participate through video conference and vote at the 40[th] AGM. She also explained the procedural and technical aspects of the 40th AGM to the members.

The Company Secretary further informed that the Register of Directors & KMPs (including their shareholding) maintained under Section 170 and the Register of Contract maintained under Section 189 of the Companies Act, 2013, are made available electronically for inspection by the Members during the 40[th] AGM. Members seeking to inspect such documents can send their request to the official email ID.

Afterward, the company secretary requested the chairman to address the shareholders.

The Chairman addressed the shareholders, highlighting key aspects of the company's performance and financial position. He discussed the diversification of the company's product offerings into key international markets, including the United States, Canada, CIS countries, and the Middle East. Additionally, he stated that on a geographic standpoint, Sub-Saharan Africa remains our largest market, and also provided details on recent investments aimed at expanding capacity. The Chairman also announced the final dividend rate declared by the company at this 40[th] AGM. After that, he requested Mr. Gagan Harsh Sharma, Managing Director of the Company to deliver his speech.

Mr. Gagan Harsh Sharma, the Managing Director, delivered a speech highlighting the company's business performance. He outlined a positive business outlook for the Semi-Solid dosage segment. He also stated that ANDAs approvals secured in FY25 for the U.S. market have been successfully commercialized, with volumes in line with budgetary expectations. Mr. Sharma further stated about the commencement of commercial supplies for two products to Canada and the UK from the Vevoor site. Additionally, efforts are underway to triple the suppository manufacturing capacity at our USFDA and EU GMP-approved plant. The company is now wellpositioned to enter a new phase of growth, supported by the strategic investments in capabilities

==> picture [452 x 65] intentionally omitted <==

==> picture [452 x 40] intentionally omitted <==

and capacities made over the past 2–3 years. After his remarks, Mr. Sharma invited Mr. Nandkumar Chodanakr, the Chairman, to continue with the proceedings.

The Notice convening the 40[th] AGM as a part of the Annual Report for the Financial Year 20242025 and the report of Statutory Auditors (being non-qualified) were taken as read. The Chairman also informed the member that, observations of the Secretarial Auditor which are self-explanatory and have been provided in the Board Report of the Company on page no. 48 of the Annual Report. The Secretarial Auditors Report was taken as read.

The following items of business as set out in the Notice convening the 40[th] AGM were recommended by the Chairman for consideration, approval & adoption by the shareholders.

Ordinary Business:

1. Consideration and Adoption of the Audited Standalone Financial Statements for the financial year ended March 31, 2025, together with the Reports of the Board of Directors and the Auditors thereon and the Audited Consolidated Financial Statements for the financial year ended March 31, 2025, and the reports of auditors thereon by way of Ordinary Resolution;

2. Declaration of Final dividend of 50% i.e., Re. 0.50 paisa per equity share on the face value of Re. 1/- each for the Financial Year ended March 31, 2025, by way of Ordinary Resolution;

3. Re-Appointment of Dr. Vibha Gagan Sharma (DIN: 02307289) as a Director of the Company, who retires by rotation, and being eligible, offers herself for re-appointment by way of Ordinary Resolution;

Special Business:

1. Appointment of M/s. AVS & Associates, Company Secretaries as Secretarial Auditors of the Company by way of Ordinary Resolution.

The Chairman then requested members to raise their queries on the agenda items as set out in the Notice convening the 40[th] AGM of the Company. Several speaker shareholders spoke/raised queries on the financial statement, business operations and other relevant matters.

Necessary clarifications/responses were provided to the members jointly by the Managing Director of the Company.

After that, Mr. Nandkumar Chodankar, Chairman then informed the members about the following:

• a) E - voting on the CDSL platform would continue for another 15 minutes to enable the members to cast their votes who have not cast their votes through remote e-voting;

==> picture [452 x 65] intentionally omitted <==

==> picture [452 x 40] intentionally omitted <==

• b) The Board of Directors had appointed Mr. Vijay Yadav, Practicing Company Secretary as a Scrutinizer for scrutiny of the votes cast through the remote e-voting platform and electronic voting at the 40[th] AGM.

• c) E-voting results along with the Scrutinizer's Report would be announced within 2 working days from the conclusion of the meeting and the same would be intimated to the Stock Exchanges and also be uploaded on the website of the Company and CDSL.

• d) Authority to Ms. Aditi Bhatt, Company Secretary of the Company, to receive the Scrutinizer Report from the Scrutinizer and declare the results of the 40[th] AGM.

• Ms. Aditi Bhatt, thereafter, thanked all the members for their participation at the 40[th] AGM.

The meeting concluded at 12.55 p.m.

This is for your information and record.

==> picture [452 x 65] intentionally omitted <==